https://investors.pepgen.com/news-releases/news-release-details/pepgen-announces-first-participant-dosed-phase-1-clinical-trial
A year ago PepGen raised over $108 million
For a phase 1 trial in DMD
The beauty of raising more money than wanted is that PepGen can start another trial in another indication
They have increased their staff from 20 to 40…
Rival to Sarepta
Will their trial be a success ?
IMO; No
https://investors.pepgen.com/news-releases/news-release-details/p...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.0¢ |
Change
0.006(9.38%) |
Mkt cap ! $62.20M | |||
| Open | High | Low | Value | Volume |
| 6.6¢ | 7.1¢ | 6.5¢ | $133.0K | 1.926M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2782 | 7.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.2¢ | 110740 | 3 |
View Market Depth
| Last trade - 15.46pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
6.8¢ |
Change
0.006 ( 14.3 %) |
||||
| Open | High | Low | Volume | ||
| 6.6¢ | 7.1¢ | 6.6¢ | 295714 | ||
| Last updated 15.58pm 26/04/2024 ? | |||||
| PER (ASX) Chart |